Cargando…

Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice

OBJECTIVE: The objective of this study was to examine how COPD patients were classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometry-based severity system and the distribution of COPD severity using the new GOLD 2011 assessment framework. MATERIALS AND METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández, Marcos, García, Gabriel, Falco, Jimena, García, Agustín R, Martín, Vanina, Ibarrola, Manuel, Quadrelli, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777377/ https://www.ncbi.nlm.nih.gov/pubmed/29403272 http://dx.doi.org/10.2147/COPD.S112551

Ejemplares similares

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort
por: Le, Lan Ai Kieu, et al.
Publicado: (2019)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

Is ‘GOLD’ standard for the management of COPD in clinical practice?
por: Yawn, Barbara P
Publicado: (2012)

Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification
por: Verhage, Tewe L, et al.
Publicado: (2009)

Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
por: Sansbury, Leah B, et al.
Publicado: (2021)

Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity
por: Moya-Álvarez, Virginia, et al.
Publicado: (2020)

Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry
por: Kobayashi, Seiichi, et al.
Publicado: (2018)

A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD
por: Crisafulli, Ernesto, et al.
Publicado: (2021)

Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
por: McDonnell, Melissa J., et al.
Publicado: (2021)

The impact of hydration status and fluid distribution on pulmonary function in COPD patients
por: Orea-Tejeda, Arturo, et al.
Publicado: (2022)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Real-Life GOLD 2011 Implementation: The Management of COPD Lacks Correct Classification and Adequate Treatment
por: Koblizek, Vladimir, et al.
Publicado: (2014)

Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial
por: Arkhipov, Vladimir, et al.
Publicado: (2017)

Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China
por: Hu, Yu-He, et al.
Publicado: (2018)

Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019
por: Halpin, David M.G., et al.
Publicado: (2019)

The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD
por: Flynn, Robert W. V., et al.
Publicado: (2018)

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification
por: Lin, Yi-Hua, et al.
Publicado: (2016)

GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study
por: Bhatta, Laxmi, et al.
Publicado: (2020)

Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
por: Tzanakis, Nikolaos, et al.
Publicado: (2021)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

COPD classification models and mortality prediction capacity
por: Aramburu, Amaia, et al.
Publicado: (2019)

Differences in Survival of Patients With COPD According to the New GesEPOC 2021 Classification of Phenotypes
por: Ji, Zichen, et al.
Publicado: (2022)

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study
por: Calle Rubio, Myriam, et al.
Publicado: (2017)

Impact of changing GOLD guidelines (2007–2011–2017) on assignment of a COPD patient to disease severity category
por: Nowak, Marcin, et al.
Publicado: (2018)

Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
por: Buero, Agustín, et al.
Publicado: (2019)

Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD
por: Papala, Maria, et al.
Publicado: (2013)

Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data
por: Ruiz-Irastorza, Guillermo, et al.
Publicado: (2020)

BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study
por: Funk, Georg-Christian, et al.
Publicado: (2009)

Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study
por: Chan, Hiang Ping, et al.
Publicado: (2016)

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
por: Moretz, Chad, et al.
Publicado: (2020)

Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study
por: Ray, Riju, et al.
Publicado: (2019)

2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages
por: Bernabeu-Mora, Roberto, et al.
Publicado: (2020)

Bronchiectasis associated with severe COPD: Clinical, functional, microbiological and tomographic features
por: Doria da Silva, Silvia Maria, et al.
Publicado: (2022)

Correlation of Plasma Protein Carbonyls and C-Reactive Protein with GOLD Stage Progression in COPD Patients
por: Torres-Ramos, Yessica D, et al.
Publicado: (2009)

Meeting the GOLD Standard: COPD Treatment in the UK Today
por: Calverley, P.M.A.
Publicado: (2019)

Validation of the GOLD 2017 and new 16 subgroups (1A–4D) classifications in predicting exacerbation and mortality in COPD patients
por: Han, Meng-Zhi, et al.
Publicado: (2018)

Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients
por: Løkke, Anders, et al.
Publicado: (2022)

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
por: Wright, Antony, et al.
Publicado: (2022)

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications
por: Ding, Bo, et al.
Publicado: (2017)

Sarcopenia in COPD: relationship with COPD severity and prognosis
por: Costa, Tatiana Munhoz da Rocha Lemos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6j5vmfvju62afm3ohgnn6p8njp